Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
Mechanically ventilated patients’ respiratory function can be improved with pulmonary rehabilitation, especially IMT and NMES.
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Pulmonary Rehabilitation Improves Respiratory Function in Ventilated Patients: Meta-Analysis Reveals
China: A new meta-analysis published in BMC Pulmonary Medicine found that pulmonary rehabilitation in mechanically ventilated ...
The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence found in previous ...
Background: Pulmonary rehabilitation has become a standard of care for patients with chronic lung diseases. This document provides a systematic, evidence-based review of the pulmonary ...
Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...
17 Since pulmonary toxicity resulting from high oxygen ... in the viscosity and type of secretion are all consequences of therapy. The loss of ciliary mucosa, at first by necrosis and later ...
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results